HIV / AIDS in the News

Experts flag cardiovascular risks among people with HIV - The Times of India

 

Cardiac care must become integral to long-term HIV treatment, say experts - The Hindu

 

Reel by Trust TV (@trusttv_news) · August 29, 2026 - instagram.com

 

As People With HIV Age, Who is the Best Medical Provider for Them? - Contagion Live

 

HIV Testing in 2026: Strategies, Challenges, and Innovations - Infectious Disease Special Edition

 

Switching to Cabenuva Can Mean Better Outcomes for Some People Living with HIV - Infectious Disease Special Edition

 

New HIV research raises hope for potential cure strategy - KESQ

 

Cabenuva Maintains HIV Suppression Despite Adherence Issues - Infectious Disease Special Edition

 

FDA Approves Gilead’s Single-Tablet Regimen Bixlenvo for People Living With HIV - Infectious Disease Special Edition

 

HIV/HBV/HCV Test Kits Market to Reach US$ 13.4 Billion by 2034, Growing at 6.1% CAGR - Market.us Media

 

Maternal engagement in HIV care associated with pediatric viral suppression - 2 Minute Medicine

 

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV - MedPage Today

 

A prevention campaign addresses the rise in HIV cases among Latinos - CaloNews.com

 

Lurie appoints 19 to HIV council, including new faces - Bay Area Reporter

 

ACTG Evaluates Osteoporosis Treatment as Novel Approach Targeting the HIV Reservoir - POZ

 

AI, telehealth can ease communication about sexual health, HIV prevention - KLAS 8 News Now

 

AI, telehealth can ease communication about sexual health, HIV prevention - Yahoo

 

AI, telehealth can ease communication about sexual health, HIV prevention – KLAS - KLAS 8 News Now

 

FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients - Managed Healthcare Executive

 

What to Know from the FDA’s End of August Activity - PharmTech.com

 

FDA Approves Gilead's Bixlenvo, Smallest Once-Daily Single Tablet Regimen for HIV - Contagion Live

 

Former teacher charged with child sex crimes, HIV exposure released on bond - ABC Columbia

 

FDA Approves Gilead’s Bixlenvo, Once-Daily Pill for Virologically Suppressed Adults with HIV - Contract Pharma

 

FDA Approves Bixlenvo Once-Daily Single-Tablet Regimen for Virologically Suppressed Adults With HIV - Pharmacy Times

 

1,209 HIV-positive patients have undergone cardiac procedures at Jayadeva since 2013 - The Hindu

 

Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection - TradingView

 

FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes - Pharmaceutical Executive

 

HIV Age Positively | Gilead - Gilead Sciences

 

Compound with the potential to treat drug-resistant HIV identified - Phys.org

 

Community gathers to fight HIV stigma in Shreveport - KTALnews.com